BIMI Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

Stats
Today's Volume	30 186.00
Average Volume	50 979.00
Market Cap	14.83M
EPS	$0.260 ( 2023-11-22 )
Next earnings date	( $0 ) 2024-05-17
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.200
ATR14	$0.0640 (5.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-29	Smith Symington Wei	Sell	0	Common Stock
2024-02-26	Tiewei Song	Sell	724	Common Stock
2024-02-28	Tiewei Song	Sell	4 000	Common Stock
2024-01-02	Oudom Fnu	Buy	2 000 000	Common Stock
2023-12-28	Oudom Fnu	Buy	214 044	Common Stock

INSIDER POWER
99.90
Last 92 transactions
Buy: 93 683 327 \| Sell: 39 865 833

Volume Correlation

Long: -0.18 (neutral)

Short: -0.61 (weak negative)

Signal:(53.784) Neutral

BOQI International Correlation

10 Most Positive Correlations
KTTA	0.941
LVTX	0.933
AFMD	0.926
IMCC	0.925
SNDL	0.92
NVAX	0.919
MIRO	0.918
INCR	0.917
NDAQ	0.915
GNOG	0.914

10 Most Negative Correlations
BCOR	-0.939
LSCC	-0.932
LIBY	-0.932
TGLS	-0.931
PDFS	-0.926
HQI	-0.922
INSE	-0.918
MCFT	-0.917
STAY	-0.917
IVAC	-0.916

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BOQI International Correlation - Currency/Commodity

-0.48
( neutral )

-0.37
( neutral )

0.00
( neutral )

0.20
( neutral )

0.39
( neutral )

0.75
( moderate )

BOQI International Financials

Annual	2022
Revenue:	$11.83M
Gross Profit:	$1.95M (16.48 %)
EPS:	$-8.12

Q3	2023
Revenue:	$2.52M
Gross Profit:	$115 155 (4.56 %)
EPS:	$-0.490

Q2	2023
Revenue:	$5.56M
Gross Profit:	$2.88M (51.89 %)
EPS:	$0.230

Q1	2023
Revenue:	$3.20M
Gross Profit:	$1.69M (52.86 %)
EPS:	$-0.230

Financial Reports:

No articles found.

BOQI International

BIMI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes generic drugs, Chinese herbal medicine, biochemical drugs, raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, health foods, sundry products, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BOQI International Medical Inc. and changed its name to BIMI International Medical Inc. in June 2021. BIMI International Medical Inc. was incorporated in 2000 and is based in Chongqing, the People's Republic of China.